Logo image of ALGN

ALIGN TECHNOLOGY INC (ALGN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ALGN - US0162551016 - Common Stock

165.43 USD
+1.56 (+0.95%)
Last: 12/12/2025, 8:13:43 PM
166.19 USD
+0.76 (+0.46%)
After Hours: 12/12/2025, 8:13:43 PM
Fundamental Rating

6

Taking everything into account, ALGN scores 6 out of 10 in our fundamental rating. ALGN was compared to 187 industry peers in the Health Care Equipment & Supplies industry. ALGN scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ALGN has a decent growth rate and is not valued too expensively. These ratings could make ALGN a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ALGN was profitable.
ALGN had a positive operating cash flow in the past year.
Each year in the past 5 years ALGN has been profitable.
In the past 5 years ALGN always reported a positive cash flow from operatings.
ALGN Yearly Net Income VS EBIT VS OCF VS FCFALGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

ALGN has a Return On Assets of 6.07%. This is amongst the best in the industry. ALGN outperforms 83.42% of its industry peers.
ALGN has a Return On Equity of 9.57%. This is amongst the best in the industry. ALGN outperforms 84.49% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.50%, ALGN belongs to the top of the industry, outperforming 90.37% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ALGN is above the industry average of 8.80%.
Industry RankSector Rank
ROA 6.07%
ROE 9.57%
ROIC 10.5%
ROA(3y)6.72%
ROA(5y)13.99%
ROE(3y)11.08%
ROE(5y)21.89%
ROIC(3y)11.25%
ROIC(5y)11.65%
ALGN Yearly ROA, ROE, ROICALGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

ALGN has a better Profit Margin (9.51%) than 82.35% of its industry peers.
In the last couple of years the Profit Margin of ALGN has declined.
The Operating Margin of ALGN (16.23%) is better than 86.10% of its industry peers.
In the last couple of years the Operating Margin of ALGN has declined.
The Gross Margin of ALGN (69.48%) is better than 76.47% of its industry peers.
In the last couple of years the Gross Margin of ALGN has remained more or less at the same level.
Industry RankSector Rank
OM 16.23%
PM (TTM) 9.51%
GM 69.48%
OM growth 3Y-12.06%
OM growth 5Y-4.71%
PM growth 3Y-18.59%
PM growth 5Y-10.55%
GM growth 3Y-1.95%
GM growth 5Y-0.69%
ALGN Yearly Profit, Operating, Gross MarginsALGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALGN is still creating some value.
ALGN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ALGN has been reduced compared to 5 years ago.
ALGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALGN Yearly Shares OutstandingALGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALGN Yearly Total Debt VS Total AssetsALGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 4.73 indicates that ALGN is not in any danger for bankruptcy at the moment.
ALGN's Altman-Z score of 4.73 is fine compared to the rest of the industry. ALGN outperforms 77.54% of its industry peers.
There is no outstanding debt for ALGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.73
ROIC/WACC1.19
WACC8.83%
ALGN Yearly LT Debt VS Equity VS FCFALGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.29 indicates that ALGN should not have too much problems paying its short term obligations.
The Current ratio of ALGN (1.29) is worse than 80.75% of its industry peers.
ALGN has a Quick Ratio of 1.17. This is a normal value and indicates that ALGN is financially healthy and should not expect problems in meeting its short term obligations.
ALGN has a Quick ratio of 1.17. This is in the lower half of the industry: ALGN underperforms 69.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.17
ALGN Yearly Current Assets VS Current LiabilitesALGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

ALGN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.76%.
Measured over the past years, ALGN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.91% on average per year.
The Revenue has been growing slightly by 0.56% in the past year.
The Revenue has been growing by 10.69% on average over the past years. This is quite good.
EPS 1Y (TTM)3.76%
EPS 3Y-5.96%
EPS 5Y11.91%
EPS Q2Q%11.06%
Revenue 1Y (TTM)0.56%
Revenue growth 3Y0.39%
Revenue growth 5Y10.69%
Sales Q2Q%1.82%

3.2 Future

The Earnings Per Share is expected to grow by 10.83% on average over the next years. This is quite good.
Based on estimates for the next years, ALGN will show a small growth in Revenue. The Revenue will grow by 6.37% on average per year.
EPS Next Y11.47%
EPS Next 2Y9.3%
EPS Next 3Y9.02%
EPS Next 5Y10.83%
Revenue Next Year0.51%
Revenue Next 2Y1.95%
Revenue Next 3Y2.85%
Revenue Next 5Y6.37%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALGN Yearly Revenue VS EstimatesALGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
ALGN Yearly EPS VS EstimatesALGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

ALGN is valuated rather expensively with a Price/Earnings ratio of 17.11.
85.03% of the companies in the same industry are more expensive than ALGN, based on the Price/Earnings ratio.
ALGN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 14.83 indicates a correct valuation of ALGN.
ALGN's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALGN is cheaper than 88.24% of the companies in the same industry.
ALGN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.78.
Industry RankSector Rank
PE 17.11
Fwd PE 14.83
ALGN Price Earnings VS Forward Price EarningsALGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

ALGN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ALGN is cheaper than 83.42% of the companies in the same industry.
ALGN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALGN is cheaper than 88.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.95
EV/EBITDA 14.07
ALGN Per share dataALGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

ALGN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ALGN may justify a higher PE ratio.
PEG (NY)1.49
PEG (5Y)1.44
EPS Next 2Y9.3%
EPS Next 3Y9.02%

0

5. Dividend

5.1 Amount

No dividends for ALGN!.
Industry RankSector Rank
Dividend Yield N/A

ALIGN TECHNOLOGY INC

NASDAQ:ALGN (12/12/2025, 8:13:43 PM)

After market: 166.19 +0.76 (+0.46%)

165.43

+1.56 (+0.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-03 2026-02-03/amc
Inst Owners97.81%
Inst Owner Change4.39%
Ins Owners0.69%
Ins Owner Change1.24%
Market Cap11.87B
Revenue(TTM)3.98B
Net Income(TTM)378.59M
Analysts77.39
Price Target184.44 (11.49%)
Short Float %4.48%
Short Ratio2.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.79%
Min EPS beat(2)-4.95%
Max EPS beat(2)6.53%
EPS beat(4)2
Avg EPS beat(4)1.18%
Min EPS beat(4)-4.95%
Max EPS beat(4)6.53%
EPS beat(8)5
Avg EPS beat(8)2.84%
EPS beat(12)8
Avg EPS beat(12)3.11%
EPS beat(16)9
Avg EPS beat(16)-1.08%
Revenue beat(2)0
Avg Revenue beat(2)-3.18%
Min Revenue beat(2)-6.34%
Max Revenue beat(2)-0.02%
Revenue beat(4)0
Avg Revenue beat(4)-2.42%
Min Revenue beat(4)-6.34%
Max Revenue beat(4)-0.02%
Revenue beat(8)2
Avg Revenue beat(8)-1.81%
Revenue beat(12)3
Avg Revenue beat(12)-1.6%
Revenue beat(16)3
Avg Revenue beat(16)-2.32%
PT rev (1m)2.68%
PT rev (3m)-3.19%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.4%
EPS NY rev (1m)0.27%
EPS NY rev (3m)1.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 17.11
Fwd PE 14.83
P/S 2.98
P/FCF 20.95
P/OCF 18.09
P/B 3
P/tB 3.53
EV/EBITDA 14.07
EPS(TTM)9.67
EY5.85%
EPS(NY)11.16
Fwd EY6.75%
FCF(TTM)7.9
FCFY4.77%
OCF(TTM)9.14
OCFY5.53%
SpS55.51
BVpS55.16
TBVpS46.93
PEG (NY)1.49
PEG (5Y)1.44
Graham Number109.55
Profitability
Industry RankSector Rank
ROA 6.07%
ROE 9.57%
ROCE 15.14%
ROIC 10.5%
ROICexc 11.03%
ROICexgc 12.91%
OM 16.23%
PM (TTM) 9.51%
GM 69.48%
FCFM 14.22%
ROA(3y)6.72%
ROA(5y)13.99%
ROE(3y)11.08%
ROE(5y)21.89%
ROIC(3y)11.25%
ROIC(5y)11.65%
ROICexc(3y)12.85%
ROICexc(5y)14.58%
ROICexgc(3y)15.07%
ROICexgc(5y)17.6%
ROCE(3y)16.23%
ROCE(5y)16.81%
ROICexgc growth 3Y-21.83%
ROICexgc growth 5Y-25.54%
ROICexc growth 3Y-20.41%
ROICexc growth 5Y-25.98%
OM growth 3Y-12.06%
OM growth 5Y-4.71%
PM growth 3Y-18.59%
PM growth 5Y-10.55%
GM growth 3Y-1.95%
GM growth 5Y-0.69%
F-Score7
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 51.62%
Cap/Sales 2.25%
Interest Coverage 250
Cash Conversion 80.04%
Profit Quality 149.64%
Current Ratio 1.29
Quick Ratio 1.17
Altman-Z 4.73
F-Score7
WACC8.83%
ROIC/WACC1.19
Cap/Depr(3y)145.51%
Cap/Depr(5y)194.24%
Cap/Sales(3y)5.1%
Cap/Sales(5y)6.34%
Profit Quality(3y)120.32%
Profit Quality(5y)97.89%
High Growth Momentum
Growth
EPS 1Y (TTM)3.76%
EPS 3Y-5.96%
EPS 5Y11.91%
EPS Q2Q%11.06%
EPS Next Y11.47%
EPS Next 2Y9.3%
EPS Next 3Y9.02%
EPS Next 5Y10.83%
Revenue 1Y (TTM)0.56%
Revenue growth 3Y0.39%
Revenue growth 5Y10.69%
Sales Q2Q%1.82%
Revenue Next Year0.51%
Revenue Next 2Y1.95%
Revenue Next 3Y2.85%
Revenue Next 5Y6.37%
EBIT growth 1Y-4.86%
EBIT growth 3Y-11.72%
EBIT growth 5Y5.48%
EBIT Next Year25.54%
EBIT Next 3Y10.88%
EBIT Next 5Y11.14%
FCF growth 1Y-17.43%
FCF growth 3Y-6.89%
FCF growth 5Y0.82%
OCF growth 1Y-25.75%
OCF growth 3Y-14.29%
OCF growth 5Y-0.24%

ALIGN TECHNOLOGY INC / ALGN FAQ

What is the ChartMill fundamental rating of ALIGN TECHNOLOGY INC (ALGN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALGN.


What is the valuation status of ALIGN TECHNOLOGY INC (ALGN) stock?

ChartMill assigns a valuation rating of 6 / 10 to ALIGN TECHNOLOGY INC (ALGN). This can be considered as Fairly Valued.


Can you provide the profitability details for ALIGN TECHNOLOGY INC?

ALIGN TECHNOLOGY INC (ALGN) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for ALGN stock?

The Price/Earnings (PE) ratio for ALIGN TECHNOLOGY INC (ALGN) is 17.11 and the Price/Book (PB) ratio is 3.